Results 11 to 20 of about 12,711 (259)

Primary membranous nephropathy with concomitant IgA nephropathy [PDF]

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2019
Membranous nephropathy (MN), an autoimmune glomerulonephritis which can occur in primary and secondary forms, is one of the most common inflammatory glomerulopathies in elderly patients.
Reza Khorsan   +7 more
doaj   +4 more sources

Update on New Antigens in the Pathogenesis of Membranous Nephropathy [PDF]

open access: yesEuropean Medical Journal, 2022
Previously, membranous nephropathies were divided into primary and secondary categories when the exact mechanism or pathogenetic factor were unknown. Approximately 70% accounted for primary membranous nephropathies.
Maurizio Salvadori, Aris Tsalouchos
doaj   +3 more sources

The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease [PDF]

open access: yesJournal of Nephropharmacology
Membranous nephropathy is an immune complex disease caused by subepithelial deposits. The pathological manifestations of membranous nephropathy are considered by the creation of immune complexes in the epithelial cells of the glomerular basement membrane.
Samaneh Zandifar   +3 more
doaj   +3 more sources

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy [PDF]

open access: yesBMC Nephrology, 2020
Background The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous nephropathy.
Maxime Teisseyre   +6 more
doaj   +2 more sources

Primary Membranous Nephropathy with Crescents

open access: yesIndian Journal of Kidney Diseases, 2023
We present the case of a 46-year-old patient with a history of hypertension, renal biopsy-proven primary membranous nephropathy, and a unique progression. He initially presented with edema and hypertension.
Megana Sunder   +2 more
doaj   +2 more sources

Choroidal Neovascularization in Primary Membranous Nephropathy [PDF]

open access: yesAmerican Journal of Case Reports, 2020
BACKGROUND We describe the retinal findings in a patient affected by primary membranous nephropathy (MN). CASE REPORT A 61-year-old man presented with a 3-month history of metamorphopsia and decreased visual acuity in both eyes. He was affected by nephrotic syndrome in primary MN and treated with systemic corticosteroids.
Gambato T., Francescutti L., Lanzetta P.
openaire   +5 more sources

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy

open access: yesFrontiers in Immunology, 2022
Primary membranous nephropathy (pMN) is an auto-immune disease characterized by auto-antibodies targeting podocyte antigens resulting in activation of complement and damage to the glomerular basement membrane.
Maxime Teisseyre   +15 more
doaj   +3 more sources

Membranous nephropathy [PDF]

open access: yesBrazilian Journal of Nephrology, 2023
Membranous nephropathy is a glomerulopathy, which main affected target is the podocyte, and has consequences on the glomerular basement membrane. It is more common in adults, especially over 50 years of age.
Márcio Dantas   +5 more
doaj   +3 more sources

Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy Workshop [PDF]

open access: yesGlomerular Diseases
Primary membranous nephropathy is a common cause of adult-onset nephrotic syndrome, with an overall incidence of 12 cases per million per year.
Marco Prunotto   +8 more
doaj   +2 more sources

Prognostic Factors of Proteinuria Remission in Primary Membranous Nephropathy. [PDF]

open access: yesJ Clin Med
Primary membranous nephropathy is a leading cause of nephrotic syndrome in adults, characterized by immune complex deposition in the glomerular basement membrane. Predicting proteinuria remission is essential for guiding treatment decisions, optimizing immunosuppressive therapy, and improving renal outcomes. Traditional prognostic markers, such as anti-
Krakowska-Jura K   +4 more
europepmc   +5 more sources

Home - About - Disclaimer - Privacy